Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert James Rudelius currently holds 403,392 shares of ProUroCare Medical Inc. (PUMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert James Rudelius has been a net seller of PUMD stock. They have purchased $49.9K and sold $290.6K worth of shares.
Robert James Rudelius's most recent insider trade was on Apr 15, 2026, when they sold 50,000 shares at $0.40 per share.
Robert James Rudelius serves as Executive at ProUroCare Medical Inc. (PUMD). They have executed 67 insider transactions totaling $340.5K over their tenure at the company.
Robert James Rudelius holds the position of Executive at ProUroCare Medical Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Robert James Rudelius has shown a selling trading pattern, with $49.9K in total purchases and $290.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert James Rudelius was on Sep 11, 2017, when they sold $290.6K worth of AXGN shares. This transaction involved 16,143 shares at $18.00 per share.
Robert James Rudelius currently owns 403,392 shares of ProUroCare Medical Inc. (PUMD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert James Rudelius's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert James Rudelius has 67 Form 4 filings on record as an insider at ProUroCare Medical Inc..
Set alerts for Robert James Rudelius and 40,000+ other insiders.